This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care | MicrobiomeTrials
← Back to trials NCT03743649
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care Recruiting PHASE2, PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2019-07-17Est. Completion: 2028-12-31
Enrollment target: 110 participantsLocations M D Anderson Cancer Center, Houston, Texas, United States Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States Hosptial de Cancer de Barretos, Barretos, São Paulo, Brazil Other microbiome trials you might be interested in Older Adults Hip Fracture Surgery Fascia Iliaca Block Liposomal Bupivacaine Postoperative Pain
Older patients with hip fractures often suffer from severe pain. Inadequate analgesia increases the risk of postoperativ…
Beijing, China Est. completion Jun 2028
Early-feeding
Esophagectomy with reconstruction for esophageal cancer is associated with delayed gastrointestinal recovery and substan…
Taipei, Taiwan Completed Jul 8, 2025